Medicare Enrolled
Dr. Ronald Fields, M.D.
Cardiovascular Disease · New Hope, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fields from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fields?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fields
Dr. Ronald Fields is a cardiovascular disease specialist in New Hope, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Fields performed 3,113 Medicare services across 2,327 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fields received a total of $437,436 from 63 pharmaceutical and/or device companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fields is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 22% volume in PA
$437,436 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,113
Medicare services
Top 22% in PA for cardiovascular disease
2,327
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,097 | $11 | $55 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
955 | $90 | $275 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
170 | $6 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
168 | $63 | $151 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
120 | $10 | $95 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
106 | $4 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
101 | $139 | $385 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
63 | $92 | $216 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
58 | $80 | $240 |
| Cardiac catheterization | 49 | $193 | $733 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $100 | $285 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
31 | $59 | $180 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $141 | $419 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
29 | $407 | $1,306 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
24 | $9 | $45 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $112 | $360 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 20 | $269 | $910 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
18 | $141 | $591 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
12 | $163 | $505 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.9% high complexity
0.0% medium
96.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$437,436
Total received (2018-2024)
Avg $62,491/year across 7 years
Top 1% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
969
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$285,164 (65.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$140,909 (32.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,363 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,276
2023
$38,007
2022
$32,624
2021
$61,836
2020
$62,824
2019
$155,549
2018
$66,320
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$17,967
ABIOMED
$343
Boston Scientific Corporation
$305
PFIZER INC.
$221
Novartis Pharmaceuticals Corporation
$201
E.R. Squibb & Sons, L.L.C.
$193
AstraZeneca Pharmaceuticals LP
$162
Impulse Dynamics (USA) Inc.
$160
Amgen Inc.
$145
Abbott Laboratories
$72
Esperion Therapeutics, Inc.
$56
ShockWave Medical, Inc
$48
Alnylam Pharmaceuticals Inc.
$42
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$38
Novo Nordisk Inc
$37
AGEPHA Pharma FZ LLC
$32
Edwards Lifesciences Corporation
$29
Regeneron Healthcare Solutions, Inc.
$28
Daiichi Sankyo Inc.
$27
Lexicon Pharmaceuticals, Inc.
$27
Inari Medical, Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$20
Merck Sharp & Dohme LLC
$19
Medtronic, Inc.
$18
Inspire Medical Systems, Inc.
$17
Kestra Medical Technology Services, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$14
Exact Sciences Corporation
$13
Top 3 companies account for 91.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$364,144
Amgen Inc.
$38,631
PFIZER INC.
$23,581
ABIOMED
$1,122
Boston Scientific Corporation
$1,113
E.R. Squibb & Sons, L.L.C.
$1,073
Novartis Pharmaceuticals Corporation
$897
AstraZeneca Pharmaceuticals LP
$665
Amarin Pharma Inc.
$514
Philips Electronics North America Corporation
$507
Impulse Dynamics (USA) Inc.
$463
Medtronic Vascular, Inc.
$444
BOSTON SCIENTIFIC CORPORATION
$383
Regeneron Healthcare Solutions, Inc.
$351
SANOFI-AVENTIS U.S. LLC
$290
Medtronic, Inc.
$279
Astellas Pharma US Inc
$266
Abbott Laboratories
$250
Merck Sharp & Dohme LLC
$183
Esperion Therapeutics, Inc.
$183
Novo Nordisk Inc
$179
Cook Medical LLC
$156
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$136
United Therapeutics Corporation
$125
Kowa Pharmaceuticals America, Inc.
$104
ARGON MEDICAL DEVICES, INC.
$90
Vital Connect, Inc
$76
AtriCure, Inc.
$71
Kestra Medical Technology Services, Inc.
$71
Merck Sharp & Dohme Corporation
$69
Electromed, Inc.
$69
Edwards Lifesciences Corporation
$57
Terumo Medical Corporation
$54
Lundbeck LLC
$52
W. L. Gore & Associates, Inc.
$48
ShockWave Medical, Inc
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
PORTOLA PHARMACEUTICALS, INC.
$43
Alnylam Pharmaceuticals Inc.
$42
Biosense Webster, Inc.
$42
Cardinal Health 200, LLC
$41
Cook Incorporated
$32
AGEPHA Pharma FZ LLC
$32
Exact Sciences Corporation
$31
Bardy Diagnostics, Inc.
$30
Althera Pharmaceuticals LLC
$28
AltaThera Pharmaceuticals LLC
$28
Daiichi Sankyo Inc.
$27
Lexicon Pharmaceuticals, Inc.
$27
Inari Medical, Inc.
$26
Gilead Sciences, Inc.
$24
Cardiovascular Systems Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
Kiniksa Pharmaceuticals, Ltd.
$20
PORTOLA PHARMACEUTICALS, LLC
$19
Teleflex LLC
$19
Inspire Medical Systems, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
ATRICURE, INC.
$15
IMPULSE DYNAMICS (USA) INC.
$14
Chiesi USA, Inc.
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Janssen Biotech, Inc.
$8
Top 3 companies account for 97.5% of all-time payments
Associated products mentioned in payments ›
(8324) Azurion 7 M20 · ACC2 CARDIAC CRYOSURGICAL SYSTEM · AMVUTTRA · ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE ATRICLIP LAA EXCLUSION · AVALUS · AVVIGO Guidance System · Aimovig · Arcalyst · Assure WCD · BRILINTA · BodyGuardian · CAMZYOS · CHANTIX · CLEANER · COOK MEDICAL AAA · Carnation Ambulatory Monitor · Cologuard Collection Kit · Cook Medical Advanced Tech · Cook Medical Thoracic · Cook Medical Zilver PTX · CoreValve Evolut · Corlanor · DARZALEX · DUPIXENT · Diamondback Peripheral · ELIQUIS · ENDURANT IIS · ENTRESTO · EXCLUDER AAA Endoprosthesis · EXCLUDER Iliac Branch Endoprosthesis · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Endurant · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · Glidesheath · INJECTAFER · INSPIRE · Impella · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LODOCO · LifeVest · Livalo · MITRACLIP · MULTAQ · Manta · Models · NEXLETOL · NORTHERA · ONPATTRO · OPTIMIZER · OPTIMIZER SMART SYSTEM · Optimizer · Optimizer Smart System · Ozempic · PAXLOVID · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · RESOLUTE ONYX · Repatha · Resolute · Reveal LINQ · Roszet · S · SMARTVEST · SYMPLICITY G3 · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Sotalol Hydrochloride · Soundstar · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · VIGILANT · VITALPATCH RTM · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in PA.
Geographic Context
Cardiologists within 10 mi
360
Per 100K population
55.7
County median income
$111,951
Nearest hospital
DOYLESTOWN HOSPITAL
8.7 mi
8.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fields is a clinical cardiology specialist, with above-average Medicare volume (top 22% in PA), with speaking/promotional industry engagement in the top 1% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fields experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Fields performed 1,097 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fields receive payments from pharmaceutical companies?
Yes. Dr. Fields received a total of $437,436 from 63 companies across 969 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fields's costs compare to other cardiologists in New Hope?
Dr. Fields's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fields) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in New Hope
Browse cardiologists in New Hope ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology